-

SynergenX Opens Testosterone Cypionate Therapy to Female Patients

HOUSTON--(BUSINESS WIRE)--SynergenX, national leader in customized hormone optimization, prescription weight loss, and medically supervised wellness, is expanding its hormone replacement therapy (HRT) services for women to include injections of testosterone cypionate. Beginning July 28, 2025, these services will be available at all locations nationwide.

SynergenX Opens Testosterone Cypionate Therapy to Female Patients

Share

This expansion marks the first time that female patients can access the custom-dosed testosterone cypionate injections available to male patients, enabling them to experience the benefits of injection-based testosterone therapy.

Testosterone Injections for Women

  • An Expansion of Women’s HRT – Female patients at SynergenX have long been able to receive estrogen, progesterone, and testosterone therapies in the forms of pellets and creams. Now, female patients have access to the same custom-dosed testosterone care that their male counterparts do.
  • Two paths for Testosterone Injections – Female patients will be able to choose from in-office injections or they may take part in the Self-Inject TRT program, allowing them to receive pre-filled syringes of testosterone delivered directly to their residences. Each path is guided by providers and informed by comprehensive lab analysis.
  • Comprehensive Medical Onboarding – Female patients can begin treatment after an in-depth medical evaluation that includes an Autonomic Nervous System (ANS) test, metabolic panel, and a comprehensive hormone panel. Unlike male patients, women may begin therapy immediately upon presenting at least one qualifying symptom and receiving provider confirmation.

Raising the Standard in Women’s Hormone Health

Hormonal imbalances in women are often overlooked or treated with generic solutions. Developed in response to widespread clinical need, this program combines laboratory-grade diagnostics, expert clinical oversight, and flexible treatment delivery models, creating a new standard of care that prioritizes efficacy, safety, and long-term results.

“Testosterone cypionate injections are the gold standard of testosterone therapy, and I’m proud that our female patients can now have access to this life-changing treatment,” said Wayne Wilson, Founder and CEO of SynergenX. “At SynergenX we are committed to helping patients improve their lives through medically supervised hormone therapy, tailored to each individual according to need.”

About SynergenX

Headquartered in Houston, TX, SynergenX is an award-winning network of hormone health and wellness clinics serving Texas and Illinois. Lauded for its commitment to the highest clinical standards and custom-dosed hormone therapies, SynergenX is a front-runner in provider-led hormone therapy, weight loss, and wellness.

Contacts

Media Contact:
Jordan Bailey
Marketing Communications Specialist, SynergenX / Low T Center
8326391569
jbailey@synergenxhealth.com

SynergenX


Release Versions

Contacts

Media Contact:
Jordan Bailey
Marketing Communications Specialist, SynergenX / Low T Center
8326391569
jbailey@synergenxhealth.com

Social Media Profiles
More News From SynergenX

SynergenX Opens New Tyler Clinic with Grand Opening Celebration

TYLER, Texas--(BUSINESS WIRE)--SynergenX, the largest provider of both in-clinic and telemedicine hormone optimization services, continued its strategic growth with the opening of its newest clinic in Tyler, expanding access to personalized, provider-led hormone optimization and wellness care for East Texas residents. The new location reflects SynergenX's continued investment in meeting the growing demand for comprehensive wellness services. The Tyler clinic offers testosterone replacement ther...

SynergenX Launches "Know Your Baseline" Initiative to Expand Access to Personalized Women's Hormone Care

HOUSTON--(BUSINESS WIRE)--SynergenX today announced the launch of Know Your Baseline, a new initiative designed to help women better understand their hormone health through comprehensive testing, personalized treatment, and collaborative care. While hormone conversations often begin during perimenopause, many women experience symptoms such as fatigue, low libido, brain fog, mood changes, poor recovery, weight changes, and difficulty building muscle years earlier. Whether those symptoms are rela...

SynergenX Launches "$250 for 250" Initiative to Expand Access to Personalized TRT

HOUSTON--(BUSINESS WIRE)--SynergenX, rapidly-growing leader in optimized hormone health and weight loss, is commemorating America's 250th anniversary with its "250 for 250" initiative, a limited-time promotion designed to make personalized testosterone replacement therapy (TRT) and hormone replacement therapy (HRT) more accessible while encouraging men and women to invest in their long-term health.Throughout July, eligible new male and female patients who begin TRT at a SynergenX, Low T Center,...
Back to Newsroom